@article{Karachentsev_Kravchun_Tykhonova_Cherniaieva_Chervenko_2021, title={State cellular immunity in patients with diabetes mellitus depending on the balance of uric acid}, volume={65}, url={https://www.jpep.endocrinology.org.ua/index.php/1/article/view/190}, DOI={10.21856/j-PEP.2018.3.02}, abstractNote={<p>91 patients with diabetes mellitus (DM), including 28 patients with type 1 diabetes, 37 patients with type 2 diabetes and 26 patients with type 2 diabetes with developed absolute insulin deficiency, were examined. Based on the results of monoclonal antibodies determination in patients with DM, regardless of the type of disease, a significant decrease in the CD8+ — T-suppressor / cytotoxic lymphocyte content was established in combination with a significant increase in the relative amount of CD16+ — T-natural killers and CD20+ B lymphocytes. In type 1 diabetes, violations of purine metabolism lead to a further statistically significant decrease in the relative amount of CD8+ — T suppressors / cytotoxic lymphocytes, as evidenced by the growth of IRI. In patients with type 2 diabetes, impairment of purine metabolism is accompanied by a significant increase in the relative amount of CD3+ — mature T lymphocytes, CD8+ — T-suppressors/cytotoxic lymphocytes and a decrease in the level of IRI compared to those in patients with type 2 diabetes with normal uric acid levels. However, these changes in patients with type 2 DM in the development of purine dismetabolism do not lead to the normalization of these indicators, and these disorders are combined with the subsequent significant increase in the relative amount of CD16+ — T-natural killers in this cohort of patients.</p>}, number={3}, journal={Problems of Endocrine Pathology}, author={Karachentsev , Y. I. and Kravchun, N. A. and Tykhonova, T.M. and Cherniaieva, A. A. and Chervenko, H. L.}, year={2021}, month={Jul.}, pages={16-23} }